Zhonghong Pulin Medical Products Co. Ltd. (300981) — Capital Reinvestment Ratio
Latest as of March 2025:
0.66x
Zhonghong Pulin Medical Products Co. Ltd. (300981) has a Capital Reinvestment Ratio of 0.66x as of March 2025, meaning it reinvests 1% of its operating cash flow (CN¥10.91 Million) in capital expenditures (CN¥7.24 Million). See 300981 FCF generation index to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
0.66x
Capex / Operating Cash Flow
Operating Cash Flow
CN¥10.91 Million
CNY
Capital Expenditures
CN¥7.24 Million
CNY
Data as of
Mar 2025
Most recent filing
Zhonghong Pulin Medical Products Co. Ltd. Capital Reinvestment Ratio (2013–2024)
This chart tracks Zhonghong Pulin Medical Products Co. Ltd.'s Capital Reinvestment Ratio across 12 annual periods.
Annual Capital Reinvestment Ratio for Zhonghong Pulin Medical Products Co. Ltd. (2013–2024)
Year-by-year Capital Reinvestment Ratio for Zhonghong Pulin Medical Products Co. Ltd. from 2013 to 2024. For live market cap and broader valuation context, see 300981 market cap overview.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 0.58x | CN¥183.91 Million | CN¥107.40 Million | ▼ -20.4% |
| 2023 | 0.73x | CN¥140.68 Million | CN¥103.17 Million | ▼ -62.3% |
| 2022 | 1.95x | CN¥106.71 Million | CN¥207.65 Million | ▲ +378.6% |
| 2021 | 0.41x | CN¥2.36 Billion | CN¥960.56 Million | ▲ +157.5% |
| 2020 | 0.16x | CN¥2.72 Billion | CN¥429.43 Million | ▼ -80.7% |
| 2019 | 0.82x | CN¥184.38 Million | CN¥150.48 Million | ▼ -90.4% |
| 2018 | 8.54x | CN¥23.77 Million | CN¥203.05 Million | ▲ +950.7% |
| 2017 | 0.81x | CN¥96.03 Million | CN¥78.09 Million | ▲ +34.9% |
| 2016 | 0.60x | CN¥102.37 Million | CN¥61.69 Million | ▼ -54.0% |
| 2015 | 1.31x | CN¥92.23 Million | CN¥120.92 Million | ▲ +925.8% |
| 2014 | 0.13x | CN¥133.33 Million | CN¥17.04 Million | ▼ -83.2% |
| 2013 | 0.76x | CN¥13.37 Million | CN¥10.15 Million | — |
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow